HUTCHMED (NASDAQ:HCM) Shares Gap Up – What’s Next?

HUTCHMED (China) Limited (NASDAQ:HCM)’s stock price gapped up before the market opened on Wednesday . The stock had previously closed at $14.95, but opened at $15.42. HUTCHMED shares last traded at $15.75, with a volume of 9,897 shares trading hands.

HUTCHMED Stock Performance

The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.68 and a current ratio of 2.81. The business has a 50 day moving average of $14.65 and a 200-day moving average of $16.53.

Institutional Trading of HUTCHMED

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Public Employees Retirement System of Ohio bought a new stake in shares of HUTCHMED during the 3rd quarter valued at $35,000. Barclays PLC increased its stake in HUTCHMED by 1,483.6% in the 4th quarter. Barclays PLC now owns 2,407 shares of the company’s stock worth $35,000 after acquiring an additional 2,255 shares during the last quarter. Blue Trust Inc. increased its stake in HUTCHMED by 99.9% in the 4th quarter. Blue Trust Inc. now owns 7,068 shares of the company’s stock worth $102,000 after acquiring an additional 3,532 shares during the last quarter. Summit Trail Advisors LLC increased its stake in HUTCHMED by 14.4% in the 4th quarter. Summit Trail Advisors LLC now owns 13,090 shares of the company’s stock worth $189,000 after acquiring an additional 1,647 shares during the last quarter. Finally, OLD Mission Capital LLC bought a new position in HUTCHMED in the 4th quarter worth about $230,000. 8.82% of the stock is currently owned by institutional investors.

About HUTCHMED

HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments. The Oncology/Immunology segment includes the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases.